Collectively, these observations in the overlap between COVID-19 and AngII/AT1R signaling in CVD pathology indicate that when combined, RAS dysregulation may contribute to an exacerbated inflammatory response and a greater degree of tissue damage to increase the severity of disease progression. The gene discussed is AGTR1; the disease is COVID-19.